Atlas Trials

Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT03140943 · UNKNOWN

Trial details

NCT number
NCT03140943
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed and/or Refractory Multiple Myeloma
Start date
2017-09-13
Primary completion
2019-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.